SI1513846T1 - Postopek za pripravo olanzapina form I - Google Patents

Postopek za pripravo olanzapina form I

Info

Publication number
SI1513846T1
SI1513846T1 SI200332002T SI200332002T SI1513846T1 SI 1513846 T1 SI1513846 T1 SI 1513846T1 SI 200332002 T SI200332002 T SI 200332002T SI 200332002 T SI200332002 T SI 200332002T SI 1513846 T1 SI1513846 T1 SI 1513846T1
Authority
SI
Slovenia
Prior art keywords
preparation
olanzapine form
olanzapine
methyl
benzodiazepine
Prior art date
Application number
SI200332002T
Other languages
English (en)
Inventor
Hiren V Patel
Anup K Ray
Pramod B Patel
Mahendra R Patel
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SI1513846T1 publication Critical patent/SI1513846T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200332002T 2002-05-31 2003-05-30 Postopek za pripravo olanzapina form I SI1513846T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16095802A 2002-05-31 2002-05-31
EP03736771A EP1513846B1 (en) 2002-05-31 2003-05-30 Process of preparation of olanzapine form i
PCT/US2003/017186 WO2003101997A1 (en) 2002-05-31 2003-05-30 Process of preparation of olanzapine form i

Publications (1)

Publication Number Publication Date
SI1513846T1 true SI1513846T1 (sl) 2011-11-30

Family

ID=29709737

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332002T SI1513846T1 (sl) 2002-05-31 2003-05-30 Postopek za pripravo olanzapina form I

Country Status (7)

Country Link
US (2) US7297789B2 (sl)
EP (1) EP1513846B1 (sl)
AT (1) ATE500258T1 (sl)
AU (1) AU2003237305A1 (sl)
DE (1) DE60336226D1 (sl)
SI (1) SI1513846T1 (sl)
WO (1) WO2003101997A1 (sl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
EP1575962A1 (en) * 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
PL1611139T3 (pl) * 2003-12-22 2008-10-31 Teva Pharma Sposób wytwarzania olenzapiny
EP1711503A1 (en) * 2004-01-27 2006-10-18 Synthon B.V. Synthesis of olanzapine and intermediates thereof
AR047459A1 (es) 2004-01-27 2006-01-18 Synthon Bv Sales estables de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (olanzapina)
AR048272A1 (es) * 2004-03-18 2006-04-12 Lek Pharmaceuticals Sintesis de 2 metil - 4- (4- metil -1- piperazinil) - 10 h- tieno ( 2,3-b) (1,5) benzodiazepina y sus sales, metodos para su preparacion, composiciones farmaceuticas que la contienen y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mentales.
US8044196B2 (en) * 2004-07-14 2011-10-25 Jubilant Organosys Limited Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
SI21850A (sl) * 2004-07-28 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
KR20070113277A (ko) * 2005-03-21 2007-11-28 닥터 레디스 레보러터리즈 리미티드 올란자핀의 결정 형태 ｉ의 제조방법
WO2007020080A1 (en) * 2005-08-17 2007-02-22 Synthon B.V. A process for making olanzapine form i
HUP0501046A2 (en) 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
ES2279715B1 (es) 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US7834176B2 (en) * 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
US8106188B2 (en) * 2006-06-01 2012-01-31 Aurobindo Pharma Ltd Process for preparing olanzapine form I
WO2007144901A1 (en) * 2006-06-12 2007-12-21 Jubilant Organosys Limited Process for stabilization of olanzapine polymorphic form i
PL381564A1 (pl) * 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
CA2593407A1 (en) * 2007-06-22 2008-12-22 Apotex Pharmachem Inc. Improved processes for the synthesis of olanzapine
EP2292624A1 (en) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Process for the purification of olanzapine
CN102268010A (zh) * 2011-06-17 2011-12-07 大连美罗大药厂 一种奥氮平的制备方法和精制方法
KR101489062B1 (ko) * 2013-03-28 2015-02-02 동아에스티 주식회사 고순도의 올란자핀 및 이의 결정형 ii의 제조방법
CN109456336A (zh) * 2017-09-06 2019-03-12 万全万特制药江苏有限公司 奥氮平的精制方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH554362A (de) * 1970-07-30 1974-09-30 Spofa Vereinigte Pharma Werke Verfahren zur herstellung von neuen estern tricyklischer piperazinoalkanole.
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
US5627178A (en) * 1991-04-23 1997-05-06 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5817656A (en) * 1991-04-23 1998-10-06 Eli Lilly And Company Mental disorders
US5817655A (en) * 1991-04-23 1998-10-06 Eli Lilly And Company Methods of treatment using a thieno-benzodiazepine
US5817657A (en) * 1991-04-23 1998-10-06 Eli Lilly And Company Psychoactive substance disorders
EG23659A (en) 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG24221A (en) 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
CR5278A (es) 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
RS49597B (sr) * 1996-09-23 2007-06-04 Eli Lilly And Company, Olanzapin dihidrat d
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
DK1155696T3 (da) 1997-04-15 2004-07-12 Lilly Co Eli Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse
CA2304472A1 (en) 1997-09-30 1999-04-08 Pierre Van Tran Method for treating sexual dysfunction
WO2001047933A1 (en) 1999-12-28 2001-07-05 Cipla Limited New polymorphic forms of olanzapine
US7022698B2 (en) * 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
US6348458B1 (en) * 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
JP2004507548A (ja) 2000-08-31 2004-03-11 ドクター・レディーズ・ラボラトリーズ・リミテッド オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法
US6740753B2 (en) * 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
US20030097650A1 (en) * 2001-10-04 2003-05-22 International Business Machines Corporation Method and apparatus for testing software
EP1440074A1 (en) 2001-10-29 2004-07-28 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
US6906062B2 (en) 2001-12-24 2005-06-14 Sun Pharmaceutical Industries Limited Crystalline form I of 2-methyl-4-(4-menthyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
WO2007020080A1 (en) 2005-08-17 2007-02-22 Synthon B.V. A process for making olanzapine form i

Also Published As

Publication number Publication date
AU2003237305A1 (en) 2003-12-19
DE60336226D1 (de) 2011-04-14
WO2003101997A1 (en) 2003-12-11
EP1513846A1 (en) 2005-03-16
US20080188465A1 (en) 2008-08-07
US7297789B2 (en) 2007-11-20
US20040048854A1 (en) 2004-03-11
ATE500258T1 (de) 2011-03-15
EP1513846B1 (en) 2011-03-02

Similar Documents

Publication Publication Date Title
SI1513846T1 (sl) Postopek za pripravo olanzapina form I
SG145744A1 (en) Process for the preparation of 4-amino-3- quinolinecarbonitriles
ZA200504238B (en) Thieno[3,2-b]pyridine-6-carbonitriles and thienoo[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
MY129439A (en) Polymorphic clopidogrel hydrogensulphate form
BR0114031A (pt) Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina
AR002719A1 (es) Forma ii polimorfa 2-metil-4-(4-metil-1-piperacinil)-10h-tieno[2,3-b]-[1,5] benzodiacepina(olanzapina) y formulaciones farmaceuticas que las contienen.
AP2004002981A0 (en) Method for the preparation of hexahydro-furo [2,3-B]furan-3-o1.
WO2005090359A3 (en) Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof
NZ510208A (en) Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) pamoate salt
MXPA04012200A (es) Proceso para preparacion de olanzapina e intermediario de la misma.
UA80881C2 (en) New polymorphs of olanzapine hydrochloride
NZ332037A (en) Olanzapine for treating migraine pain
EP0911028A3 (en) Method for treating sexual dysfunction
WO2003037903A8 (en) Olanzapine dihydrate-ii a process for its preparation and use thereof
AU2003292452A1 (en) A process for the preparation of a pharmaceutically pure polymorphic form i of olanzapine
MX9707936A (es) Compuestos para tratar disfunciones del conocimiento.
WO2007087555A3 (en) Novel polymorph 'form e ' of olanzapine (2-methyl-4- (4-methyl-1-piperazinyl) -10h-thieno [2, 3-b] [1, 5] benzodiazepine) and preparation of the anhydrous non-solvated crystalline polymorphic 'form i' of olanzapine from the polymorphic olanzapine 'form e'
AU2001234188A1 (en) Processes for the production of thienopyrimidine derivatives
AU5872596A (en) Method for treating anorexia
ECSP961694A (es) Procedimeinto para preparar olanzapina (caso x - 9992m)
SI1963335T1 (sl) Postopek za pripravo olanzapina
AU2002249279A1 (en) Method for the production of 6-aryl-4h-s-triazolo(3,4-c)-thieno(2,3-e)-1,4-diazepines
PL350717A1 (en) Method of obtaining 4-amino 2-methyl-10h-thiene[2,3-b][1,5]benzodiazepine and method of obtaining olanzapine
DK1392698T3 (da) Fremgangsmåde til fremstilling af 6-aryl-4H-s-triazolo-[3,4-c]thieno[2,3-e]-1,4-diazepiner
JO1926B1 (en) The process of forming crystalline forms of 2- methyl tinzo benzodiazepine